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Ethnopharmacological relevance: Annona muricata L. is used to treat cancer in some countries. Extracts of
Annona muricata have been shown to cause apoptosis of various cancer cells in vitro, and inhibit tumor
growth in vivo in animal models. However, the molecular mechanisms underlying its anti-cancer and
apoptotic effects of the herb remain to be explored.
Aim of study: The study investigated the molecular mechanisms underlying liver cancer cell apoptosis
triggered by the ethanol extract of leaves of Annona muricata L.
Materials and methods: Liver cancer HepG2 cells were used as experimental model. MTT assay was
employed to evaluate cell viability. Flow cytometry and TUNEL assays were performed to conﬁrm
apoptosis. We employed functional proteomic analysis to delineate molecular pathways underlying
apoptosis triggered by the herbal extract.
Results: We showed that the extract was able to reduce viability and trigger apoptosis of the cancer cells.
Proteomic analysis identiﬁed 14 proteins associated with the extract-elicited apoptosis, which included
the increased expression levels of HSP70, GRP94 and DPI-related protein 5. Western blot analysis con-
ﬁrmed that the extract did up-regulated the protein levels of HSP70 and GRP94. Results from bioinfor-
matic annotation pulled out two molecular pathways for the extract, which, notably, included en-
doplasmic reticulum (ER) stress which was evidenced by the up-regulation of HSP70, GRP94 and PDI-
related protein 5. Further examinations of typical protein signaling events in ER stress using western blot
analysis have shown that the extract up-regulated the phorsphorelation of PERK and eIF2α as well as the
expression level of Bip and CHOP.
Conclusion: Our results indicate that the ethanol extract of leaves of Annona muricata L. causes apoptosis
of liver cancer cells through ER stress pathway, which supports the ethnomedicinal use of this herb as an
alternative or complementary therapy for cancer.
& 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cancer is one of the most common non-communicable diseases
word-wide; in China alone, one cancer patient is diagnosed in
every six minutes. This casts great socio-economic burdens tor Ireland Ltd. This is an open acces
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.societies. Surgery, chemotherapy and radiotherapy are common
treatments for cancer. However, they often do not produce desir-
able outcomes and many patients are keen to seek alternative and
complementary therapies. Hopefully, ethnomedicinal treatments
can help in treating cancer as well as increase the efﬁcacy and/or
alleviate side effects of common clinical therapies (Smith et al.,
2014; Wang et al., 2015).
Annona muricata L., also known as graviola, soursop and gua-
nabana, is an evergreen tree that is seen in tropical and sub-tro-
pical areas. The plant name of Annona muricata L. is veriﬁed by the
World Checklist of Selected Plant Families (http://www.theplant
list.org/tpl1.1/record/kew-2640944) and is included in the Plant
List (www.theplantlist.org). The plant is collected by different re-
cognized herbariums such as the African Plant Database, the New
York Botanical Garden Virtual Herbarium and Royal Botanic Gar-
dens, Kew. The fruits of the plant are edible and are used tos article under the CC BY-NC-ND license
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plant has long been used in different countries as ethnomedicinal
treatment for various conditions which include cystitis, diabetes,
hypertension, headaches, insomnia, rheumatism and parasite in-
fection (Moghadamtousi et al., 2015a). More interesting, the plant
is used in South America and tropical Africa as an ethnomedicine
against tumor (Adewole and Ojewole, 2009). In keeping with the
traditional use for anti-cancer treatment, Torres and co-workers
have conﬁrmed that extract of the plant can inhibit the viability
and motility as well as induce apoptosis of pancreatic cancer cells
in vitro, and suppress tumor growth and metastasis in vivo in mice
model, which may be due to the extract-triggered down-regula-
tion of metabolism and cell necrosis (Torres et al., 2012). In EGFR-
over-expressing human breast cancer cells, extract of Annona
muricata L. fruits inhibits the growth and cause apoptosis of the
cancer cells in vitro, with no effect on non-tumorigenic human
breast epithelial cells. In mice model, the extract reduces the
protein level of EGFR in the cancer cells, and inhibits the tumor
growth (Dai et al., 2011). Moghadamtousi et al., (2015b) used rat
model with azoxymethane-induced colonic aberrant crypt foci to
examine the in vivo chemopreventive potential of the ethyl acetate
extract of the Annona muricata L. leaves, and found that their ex-
tract was able to reduce the formation of aberrant crypt foci.
Apoptotic effect of the plant extracts appears to be an important
mechanism for its anti-cancer activity, as it has been demonstrated
under different experimental conditions. In addition to pancreatic
cells (Torres et al., 2012), Pieme et al. extract the plant leaf, twigs
or roots using hot 95% ethanol, and found all extracts could induce
apoptosis of Human promyelocytic leukemia HL-60 cells (Pieme
et al., 2014). Hexane extract of leaves causes colon cancer cell (HT-
29 and HCT-116) apoptosis though the intrinsic pathway, as evi-
denced by phosphatidylserine externalization, mitochondria
transmembrane potential drop, cytochrome c release and caspase
activation. The extract also inhibits the cancer cell migration and
invasion (ZorofchianMoghadamtousi et al., 2014). In lung cancer
A549 cells, extract of the plant leave can suppress NF-κB activa-
tion, suggesting that NF-κB is involved in apoptotic signal trans-
duction (Moghadamtousi et al., 2014).
Despite the accumulated evidence for apoptotic effect of ex-
tracts of the plant on various cancer cells, the underlying mole-
cular mechanisms remain to be explored further. The present
study investigated whether the ethanol extract of Annona muricata
L. leaves could cause apoptosis using liver cancer HepG2 cells as an
experimental model. Functional proteomic analysis was per-
formed to delineate the molecular pathways underlying the ex-
tract-induced apoptosis.2. Materials and methods
2.1. Chemicals, reagents and antibodies
All chemicals, reagents, consumables and equipment for two-
dimensional gel electrophoresis were purchased from GE Health-
care life sciences (Beijing, China). Chemicals for non-proteomic
assays were from Sigma (St. Louis, MO, USA), unless otherwise
speciﬁed. Cell culture medium (DMEM), penicillin-streptomycin,
and L-glutamine were purchased from GIBCO (NY, USA). Fetal
bovine serum was a product of Hyclone (Logan, UT, USA). Anti-
bodies were purchased from Cell Signaling Technology (Denvers,
MA, USA).
2.2. Preparation of plant extract
Annona muricata L. leaves were collected from Nanning city,
Guangxi province of China. The taxonomic identity was veriﬁed byour botanist. Leaves were air dried and cut into pieces of ap-
proximately 1 cm1 cm in size. The leaf pieces were weighted
and placed into glass bottles, and 70% ethanol was added to cover
the leaf pieces. The bottles were placed in dark at room tem-
perature for 10 days, after which the supernatants were collected
by ﬁltering through Whatman 3 mm ﬁlter paper and dried using a
vacuum drier. The resulted powders were dissolved in DMSO and
stored at room temperature in the dark till use.
2.3. Cell culture
Liver cancer HepG2 and colon cancer HCT116 cells were
maintained in DMEM medium supplemented with 10% fetal bo-
vine serum, 1% L-glutamine, and 1% penicillin-streptomycin in a
humidiﬁed incubator with 5% CO2 at 37 °C. Cell cultures at ap-
proximately 70% conﬂuence were used for all experimental
treatments.
2.4. Cell viability and apoptosis assays
MTT assay was employed to quantify cell viability (Lee et al.,
2006, 2007). Approximately 7000 cells were seeded to each well
of a 96-well plateand cultured for 24 h, followed by treatment for
another 24 h (the control samples received DMSO alone). At the
end of treatment, MTT reagent (5 mg/ml, 10 μl) was added to each
well and cells were incubated for 3 h. Finally, medium was re-
moved and 150 μl DMSO was added into each well and mixed by
gentle shaking for 15 min, and optical density value of each well
was determined using a plate reader at 490 nm. Apoptosis was
evidenced and quantiﬁed using propidium iodide (PI) staining for
DNA fragmentation by ﬂow cytometry analysis (Lee et al., 2006,
2007). Cells were harvested in a 15-ml tube, ﬁxed with 70%
ethanol, and stained with PI. At least 10,000 events were analyzed
by ﬂow cytometry (FACS Calibur, Becton Dickinson, CA, USA) with
the excitation set at 488 nm and emission at 610 nm. Data were
analyzed using the built-in software package (Modﬁt). In Situ Cell
Death Detection Kit from Roche Diagnostics (Penzberg, Germany)
was used for TUNEL assay, which was to conﬁrm treatment-in-
duced apoptosis (Lee et al., 2010). Brieﬂy, HepG2 cells were grown
on Labtek chamber slides (Rochester, NY, USA), washed once with
PBS, and ﬁxed in 100% methanol at 20 °C for 10 min The ﬁxed
cells were blocked in blocking buffer (1% BSA and 0.05% Tween-20
in 1 PBS) for 1 h, followed by three washes with 1 PBS. The
cells were then incubated with the TUNEL staining solution
overnight at 4 °C and then washed three times with 1 PBS be-
fore mounting with UltraCruz Mounting Medium (Santa Cruz, CA,
USA). The cells were immediately examined by ﬂuorescent mi-
croscopy (Olympus IX73, Tokyo, Japan).
2.5. Proteomics
The two-dimensional gel electrophoresis procedure was de-
tailed in previous publications (Lee et al., 2006, 2007). Brieﬂy, IPG
polyacrylamide strips with a linear pH gradient from 4 to 7 as the
ﬁrst-dimensional gels. IPG strips were rehydrated in re-swelling
buffer for IEF using an IPGphor machine. Total cellular protein
samples were applied using sample loading cup method. Focused
IPG strips were frozen at 20 °C till use. Before the second-di-
mensional run, IPG strips were equilibrated twice in equilibration
buffer, then were placedon top of 12% SDS-PAGE (Bio-Rad PRO-
TEAN II xi cell) and sealed with 0.5% agarose containing trace
amount of bromophenol blue in running buffer for the second-
dimensional separation. Peptides separated on gels were visua-
lized by silver staining method. Gel images were captured using an
ImageScanner and analyzed using the software package Imag-
Master 2D Platinum.
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determination through peptide mass ﬁnger printing that involved
in-gel tryptic digestion, tryptic peptide mass determination by
mass spectrometry. Peptide masses were used for identiﬁcation
search using the MASCOT search engine 2.2 (Matrix Science, Ltd.)
embedded into GPS-Explorer Software 3.6 (Applied Biosystems)
on the NCBI database with the following parameter settings:
100 ppm mass accuracy, trypsin cleavage one missed cleavage al-
lowed, carbamidomethylation set as ﬁxed modiﬁcation, oxidation
of methionine was allowed as variable modiﬁcation, MS/MS frag-
ment tolerance was set to 0.4 Da. GPS Explorer protein conﬁdence
index Z95% were used for further manual validation.
2.6. Bioinformatics
For pathway annotation, amino acid sequences of proteins of
interests were retrieved from Uniprot (http://www.uniprot.org/)
and submitted to KEGG Automatic Annotation Server (Ver. 2.0;
http://www.genome.jp/tools/kaas/) to pull out pathways. We used
default parameter except that we selected BLAST for search pro-
gram, text data for query sequences, and single-directional best hit
for assignment method.
2.7. Western blot analysis
Western blot analysis was performed as described previously
(Lee et al., 2006, 2007). Cell lysates were subjected to 10% poly-
acrylamide gel electrophoresis then transferred onto PVDF mem-
branes. After blocking overnight with 5% dry milk in TBST solution
(50 m MTris/ HCl pH 7.4, 150 mM NaCl, 0.1% Tween 20), mem-
branes were washed three times using TBST, exposed to primary
antibody overnight at 4 °C with gentle shaking, washed with TBST
three times, exposed to secondary antibody for 1 h, washed three
times again in TBST, and eventually subjected to chemilumines-
cence detection using the SuperSignal Substrate Western Blotting
Kit.
2.8. Statistical analysis
All experiments were performed in triplicate. Data were ex-
pressed as mean 7 SD, and were analyzed by one way ANOVA
analysis using the statistical software package SPSS. A p o0.05
was considered to be statistical signiﬁcant.3. Results
3.1. Ethanol extract of Annona muricata L. leaves inhibited the via-
bility of liver cancer HepG and colon cancer HCT116 cells.
We ﬁrst examined the effect of the extract on cell viabilityFig. 1. The extract of Annona muricata leaves inhibited the viability of HepG2 andusing MTT assay. Clearly, the extract was able to inhibit the via-
bility of the liver cancer HepG2 (Fig. 1(A)) and colon cancer
HCT116 (Fig. 1(B)) cells in a dose- and time-dependent manner.
The values of IC50 values were estimated to be
approximately150 μg/ml for both HepG2 and HCT116 cells.
3.1.1. Ethanol extract of Annona muricata L. leaves triggered apop-
tosis of liver cance HepG cells
Next, we analyzed cell cycle of the control and treated HepG2
cells using PI staining in combination ﬂow cytometry. Results
showed that the herbal extract increased the amount of sub-
G1cells in a dose-dependent manner. It produced approximately
33% of sub-G1 cells at the concentration of 120 μg/ml (Fig. 2
(A) and (B)). We then performed TUNEL assay to conﬁrm the
apoptotic effect of the extract, which showed that the extract
signiﬁcantly increased the number of cells positive for TUNEL
staining (Fig. 2(C)).
3.1.2. Proteomic analysis identiﬁed 1 proteins associated with the
herbal extract-induced apoptosis
To look for molecular pathways underlying the extract-evoked
apoptosis, we performed traditional proteomic analysis to identity
proteins responsive to the treatment by the extract. As shown in
Fig. 3(A) and (B), the extract caused changes in 14 peptide spots on
the two dimensional gels. Subsequently, we obtained the identities
of the 14 proteins of interests through peptide mass ﬁnger printing
analyses (Table 1). They are proteins candidates of signal trans-
duction mediators for the extract-elicited apoptosis.
3.1.3. Bioinformatic annotation reveled that endoplasmic reticulum
stress was the main pathway underlying the extract-induced
apoptosis
We used the 14 identiﬁed proteins for bioinformtic annotation
for molecular pathways. Totally, 2 pathways were retrieved by
KEGG annotation. One is estrogen signaling pathway which had
included 2 of the 14 proteins, HSP70 and HSP90 (ﬁgure not
shown). The other was endoplasmic reticulum (ER) stress pathway
that had included 3 proteins (Fig. 4(A)), which were GRP94, HSP70
and PDI-related protein. Western blot conﬁrmed that the extract
did increase the expression levels of GRP94 and HSP70proteins
(Fig. 4(B)). The effect of the extract on the protein level of PDI-
relate protein was not examined by Western blot, as we had found
no commercial antibody speciﬁc to this protein.
3.2. Typical molecular events in ER stress appeared after cells were
treated by the herbal extract
Finally, we investigated typical protein signaling events in ER
stress to conﬁrm the ﬁnding from the bioinformatic annotation,HCT116 cells. (A). Liver cancer HepG2 cells; (B). Colon cancer HCT116 cells.
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Fig. 2. The extract of Annona muricata leaves evoked apoptosis of liver cancer HepG2 cells. (A). Flow cytometry analysis outcome; (B). Percentage of sub-G1 cells from ﬂow
cytometry analysis; (C). TUNEL assay outcome.
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well as increased level of phosphorylations of PERK and eIF2α. As
shown in Fig. 5, the herbal extract did increase the protein levels of
Bip and CHOP, and enhanced the phosphorylation of PERK and
eIF2α.4. Discussion
As summarized by Cassileth and Deng (Cassileth and Deng,
2004), a Data Monitor Survey shows that up to 80% of patients
have used alternative and/or complementary therapy in ﬁghting
cancer. The visits of cancer patients to alternative andcomplementary medicine practitioners outnumbered the visits of
cancer patients to U. S. primary care physicians. Medicinal plants
provide a useful resource for alternative and complementary
therapy. This shows that alternative and complementary medicine
is highly valued by patients ﬁghting against cancer. Annona mur-
icata L. extracts can inhibit proliferation and cause apoptosis of
various types of cancer cells in vitro as well as in mice models
in vivo, and can suppress tumor metastasis (Torres et al., 2012; Dai
et al., 2011; Pieme et al., 2014; Moghadamtousi et al., 2014, 2015),
which shows that Annona muricata L. provides an option for cancer
ethnomedicinal therapy.
Our results conﬁrm that leaf extract can cause apoptosis of liver
cancer cells, as evidenced by data from ﬂow cytometry and TUNEL
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Fig. 3. Proteomic analysis identiﬁed 14 peptides associated with the treatment by the extract of Annona muricata leaves. (A). Global view of the peptide spots on the two
dimensional gels. The spots responsive totreatment by the extract of Annona muricata leaves were labeled; (B). Localized view of the peptide spots on the two dimensional
gels. The spots changed by treatment by the extract of Annona muricata leaves were labeled.
Table 1.
Identiﬁcation of proteins of interests using peptide mass ﬁnger printing.
Spot no. Protein description Accession no. Protein MW (kDa) pI value (pH) Type of changeb
Score C. I.%a Calib-
rated
Theo-
retical
Calib-
rated
Theo-
retical
1 Stathmin isoform a gi|44890050 100 15–20 17 5–6 5.76 
2 Chain A, Solution Structure Of Oxidised Erp18 gi|238828062 99 15–20 17 5–6 5.66 
3 PGAM1 gi|49456447 100 25–30 28 6–7 6.67 
4 RecName: Full¼Reticulocalbin-1;Flags: Precursor gi|2493462 100 35–40 38 4–5 4.86 
5 Tumor rejection antigen (gp96)1 variant, partial gi|62088648 100 65–70 66 4–5 5.08 
6 vimentin variant, partial gi|62896523 100 50–55 54 4–5 5.06 
7 Heterogeneous nuclear ribonucleoprotein C (C1/C2) gi|14249959 100 30–40 32 4–5 5.00 þ
8 Actin, cytoplasmic 2 gi|316659409 100 40–45 42 5–6 5.31 þ
9 Actin, cytoplasmic 1 gi|46397333 100 40–45 42 5–6 5.29 þ
10 Proteasome (prosome, macropain)subunit, alpha
type1
gi|119588884 100 25–30 30 6–7 6.51 þ
11 Heterogeneous nuclear ribonucleoprotein H isoform
1
gi|767938356 100 50–55 51 6–7 6.33 þ
12 Heat shock protein 90 kDa beta (Grp94) gi|119618130 100 90–95 92 4–5 4.76 þ
13 Heat shock 70 kDa protein 8 isoform 1 variant,
partial
gi|62897129 100 70–75 71 5–6 5.28 þ
14 Protein disulﬁde isomerase-related protein 5, partial gi|1710248 100 45–50 46 4–5 4.95 þ
a Protein Score C. I.% is the conﬁdence interval of identiﬁed proteins calculated from MS data.
b (þ), protein level was up-regulatied; (), protein level was down-regulated; compared with those in the control samples.
N. Liu et al. / Journal of Ethnopharmacology 189 (2016) 210–217214assays (Fig. 2). Proteomic analysis revealed 14 proteins responsive
to the treatment by the leaf extract (Fig. 3; Table 1). Bioinformatic
annotation outcome suggests that ER stress is the pathway un-
derlying the extract-induced apoptosis, which is evidenced by the
increase in the protein levels of GRP94, HSP70 and PDI-related
protein (Fig. 4). These three proteins are ER chaperones that are
involved in the regulation of ER stress (Sozen et al., 2015). So far,
several different ER stress pathways have been delineated (Sozenet al., 2015). One of the well characterized ER stresssignal trans-
duction route is Bip-PERK-eIF2α-CHOP pathway: PERK dissociates
from Bip and becomes phosphorylated. This leads to phosphor-
ylation of eIF2α, which eventually results in the up-regulation of
CHOP expression. CHOP activates downstream proteins to cause
apoptosis (Sozen et al., 2015). Upon treatment by our Annona
muricata L. leaf extract, phosphorylations of PERK and eIF2α as
well as the protein levels of Bio and CHOP were all up-regulated
 24
GRP94
HSP70
β - actin
Treatment hour
Fig. 4. Western blot analysis conﬁrmed that the protein levels of HSP70 and GRP94 were up-regulated after treatment by the extract of Annona muricata leaves.
Bip
p-PERK
(Thr980)
p-eIF2α
(Ser51)
CHOP
β-actin
0         6        12        24  
Treatment time (hour)
Fig. 5. Western blot analysis showed that phorsphorelation of PERK and eIF2α as
well as the protein levels of Bip and CHOP were all up-regulated after treatment by
the extract of Annona muricata leaves.
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eIF2α-CHOP pathway. Since ER stress is a recognized pathway to
cause cell death including apoptosis (Verfaillie et al., 2013), it is
thus suggested that the ethanol extract of Annona muricata L.
leaves triggers the liver cancer cell apoptosis through ER stress.
Better understanding of the molecular pathways underlying the
herb-induced apoptosis is helpful for beneﬁcial use of the plant as
anti-cancer ethnomedicine.
Different parts of Annona muricata L., leaf, twigs or roots, have
active apoptotic chemical components. Leaf and root extracts have
comparable anti-proliferative activities, which are higher than
twig extract (Moghadamtousi et al., 2014). Fruit extract appears to
be more potent, which shows an IC50 value of 4.8 μg/ml in pro-
liferation inhibition (Dai et al., 2011). However, leaves are con-
sidered to be a better raw material for extraction, as they are more
abundant and available. Using 95% hot ethanol as solvent, the re-
sulting leaf extract can inhibit the proliferation of HL-60 cells at an
IC50 of less than 12 μg/ml (Moghadamtousi et al., 2014). The values
of IC50 for hexane extract are 11.4371.87 mg/ml and
8.9871.24 mg/ml against HT-29 and HCT-116 cells respectively
(Moghadamtousi et al., 2014). In various cancer cells lines that
included MCF-7, MDA-MB-231, A549, HepG2 and WRL-68, the IC50
of ethyl acetate extract was the lowest compared with those of
N. Liu et al. / Journal of Ethnopharmacology 189 (2016) 210–217216hexane and methanol extracts (Moghadamtousi et al., 2014). In
our study, 75% ethanol as solvent was used to prepare extract at
the room temperature, and he IC50 of proliferation inhibition was
150 μg/ml for liver cancer HepG2 cells after 24 h of treatment
(Fig. 1). This shows that 75% ethanol is also good solvent for the
extraction of anti-cancer ingredients from the herb. However,
compared amongst the solvents ever used for extraction, ethyl
acetate seems to be the best.
Natural products provide a useful resource for drug develop-
ment. In the area of cancer, from 1940s to December 2010, 48.6%
anti-cancer small molecule drugs developed are from natural
products or their derivatives (Newman and Cragg, 2012). The de-
velopment of natural products for cancer treatment was not fa-
vored over a short period of time, in particular in 1990s, due to the
emergence of targeted therapies which rely on synthetic com-
pounds and antibodies. However, the natural products strike back
soon, since the drawbacks of targeted therapy start to appear after
years in use. Since the approval of rapamycin in 2007, 12 novel
natural product derivatives have been brought to market for
treating cancer so far (Basmadjian et al. 2014). Since extracts of
Annona muricata L. have potent anti-cancer activities, it is logical
to look for active chemical components from extracts, which may
be further developed into mainstream drugs for the management
of cancer. As reviewed by Moghadamtousi et al. (2015a), Annona
muricata L. has alkaloids, megastigmanes, ﬂavonol triglycosides,
phenolics, cyclopeptides, essential oils and notably annonaceous
acetogenin (AGE) compounds. More than 100 AGEs have been
identiﬁed from this plant. Some AGEs are found to have toxicity
against various types of cancer cells. For examples, annomuricins
A, B, C and E from the plant leaves are toxic to lung A549, breast
MCF-7, colon HT-29 or pancreatic MIA PaCa-2 cancer cells (Wu
et al., 1995a, 1995b; Kim et al., 1998a; Jaramillo et al. 2000).
Murihexocin C and muricoreacin, also from the plant leaves, have
toxicity against prostate adenocarcinoma (PC-3) and pancreatic
carcinoma (PACA-2) cells (Kim et al., 1998b). Other AGEs, some of
which are shown to be toxic to cancer cells, are listed in the review
by Moghadamtousi and co-workers (Moghadamtousi et al. 2015a).
There is evidence that AGEs, in addition to their toxicities to
cancer cells, have unacceptable toxic side effects such as neuro-
toxicity, which may cause neurodegeneration (Champy et al.
2005). Thus, AGEs are not good drug candidates, unless chemical
modiﬁcation can maintain the apoptotic activity and reduce that
neurotoxicity (Kojima et al., 2015). The anti-cancer effect and
mechanism of extracts may be different from that of a single
chemically deﬁned compound, as active components in extracts
may have combinational effects (Chan et al., 2008). Isolation of
active single compound from extracts may not only compromise
the therapeutic efﬁcacy but also render toxicity. To this end, Yang
et al., (2015) compared the anti-cancer activity of extract of the
plant leaves, ﬂavonoid-enriched and AGE-enriched fractions, and
found that the extract was more potent in inhibitingthe pro-
liferation, viability and clonogenic capacity of prostate cancer cells
in vitro, compared to ﬂavonoid-enriched fraction. Oral adminis-
tration of the extract also showed a higher tumor growth-in-
hibitory efﬁcacy thanthe ﬂavonoid-enriched fraction in vivo in
human prostate tumor xenografts. AG-enriched fraction, although
was superior in cancer cell toxicity, caused death of mice. This
implicates that the action of extract is complex, and, extract may
be better than currently isolated chemically deﬁned single con-
stituents. It further suggests extracts of the plant leaves deserve
further development into therapeutic use.
5. Conclusion
In conclusion, our results have shown that the ethanol extract
of Annona muricata L. leaves causes apoptosis of liver cancerHepG2cells, promote phosphorylation of PERK and eIF2α, and up-reg-
ulate the protein level of Bip and CHOP. The results indicate that
the herbal extract triggers the cancer cell apoptosis through ER
stress pathway. Out data support the use of Annona muricata L.
leave extracts as ethnomedicine for the management of cancer.6. Conﬂict of interests
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